SEO URLwww.firestrike.ai/deals/astria-therapeutics-biocryst-acquisition-2026-2
acquisitionAnnounced · Jan 23, 2026PharmaceuticalsSource · CredibleArticle · Factual
BioCryst acquires Astria Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$700M
Target
Astria Therapeutics
NASDAQ: ATXS · Boston, Massachusetts
Acquirer
BioCryst
Full Acquisition
Status
Announced
BioCryst agreed to acquire Astria Therapeutics. Reported deal value: $700M. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Boston, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-23. Figures and status may change as filings and press coverage update.
BioCryst Pharmaceuticals Closes Acquisition of Astria Therapeutics BioCryst Pharmaceuticals said Friday that it has completed the acquisition of Astria Therapeutics for an implied transaction value of about $700 million, net of Astria cash at closing
Deal timeline
Announced
Jan 23, 2026 · marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $700M. Figures and status may change as sources update.
Sources: marketscreener.com · Primary article · FireStrike proprietary index